AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
PVA.MC

Pescanova, S.A. (PVA.MC) fair value

Consumer Defensive · Farm Products · BME · Spain
€0.22-2.26%
Market cap €6MUpdated Oct 24, 2026 · valuation updating
Our verdict
No fair value
We are missing the financial data our models need for this company. It will appear once the data arrives.
Not valued: the number of shares is not on file.
ACCE opinionPescanova, S.A. (PVA.MC)
Fair value
Not available
ACCE price target
€0.20
Rating
Not rated
Horizon
12 months
ACCE price target published on 23 Oct 2026, 01:52 CEST.
Price used: €0.22 at the close on 23 Oct 2026, 17:30 CEST.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
29
out of 100
1-year return
-24.1%
Dividend yield
0.00%

Pescanova, S.A. in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Pescanova is a Spanish fishing and aquaculture group best known for frozen hake, octopus, shrimp and other seafood sold through its processing plants and branded retail. The thesis rests on a long-established distribution network and vertically integrated supply in a defensive food category, but the balance sheet is the dominant issue: the company went through a court-supervised insolvency restructuring and operating margin is still slightly negative at -0.6%, with ROE of just 1.4%. Revenue growth of 2.5% is steady rather than strong, and the gross margin figure of 100.0% in our data looks like a reporting artefact rather than a usable signal, so it should not be relied on. With a market capitalisation of roughly 6 million euros and no index membership, the name is small and thinly followed, which makes any re-rating highly sensitive to restructuring outcomes and creditor dynamics. A deeper look would need to establish how much equity is left after the restructuring, whether operating profit can turn durably positive, and what the debt load is relative to cash generation.

AI-assisted·How I use AIWritten Oct 23, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where PVA.MC's valuation models land
Price
€0.22
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
+0.0%
1 month
-8.3%
3 months
-8.3%
6 months
-15.4%
YTD
-21.4%
1 year
-24.1%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 01:52 CESTACCE price target€0.20first publication€0.22

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in EUR. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full PVA.MC page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth19Value47Quality32Momentum17Total29
Valuation
Trailing P/E
no data
Forward P/E
no data
PEG
no data
P/B
5.81x
EV / Revenue
26.8x
Book value/sh
€-0.23
Enterprise value
€9M
Profitability
ROE
1.4%
FCF yield
-1.48%
ROIC
no data
Health and risk
Debt / equity
-1.47
Dividend yield
0.00%
Beta
0.55

Price

-24.1% · 1Y

Ask anything about PVA.MC

Answered from Pescanova, S.A. fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
ROEbetter than 67% of peers
low -393%1%high 28%
Div yieldbetter than 100% of peers
low 0.0%0.0%high 0.0%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
PVA.MC Pescanova, S.A.€0.22---1.4%3229
AGRZ Agroz Inc. Ordinary Shares$2.93--1.9x26.7%7862
AQB AquaBounty Technologies Inc. Common Stock$1.02----50.2%1326
TULP Bloomia Holdings Inc. Common Stock$2.28----93.5%2220
ALAGR.PA AgroGeneration SA€0.04--2.3x27.9%7455
SDOT Sadot Group Inc. Common Stock$7.37----392.8%1337
ALKKO.PA KKO International SA€0.06---0.9%4742

Sector report card

Where PVA.MC ranks against its sector peers on each metric.

Computing percentiles…